Rutella Lab retweeted
Rutella Lab retweeted
Immunogenomic landscape of p53 AML. Sergio Rutella, M.D., Ph.D., Nottingham University, UK. April 26th, Genomic Workshop &Hem Malig symposium. Georgetown MedStar Unv. hospital. Register eventbrite.com/e/genomics-wo…. @ASH_hematology @LombardiCancer @BCMCancerCenter @leukaemielabor – at Washington, DC
Rutella Lab retweeted
Farhad Ravandi, M.D., AML MRD optimization before BMT, MD Anderson CC. April 27th, 10:50 am. Goldberg auditorium, MGHU. Register: eventbrite.com/e/genomics-wo… @LombardiCancer @BCMCancerCenter @aamdsif @LLSusa @leukaemielabor @ASH_hematology @SocietyofHemOnc @HMHNewJersey – at Naples, Campania
Rutella Lab retweeted
#ESMOImmuno21: Your chance to help us shape the future of immuno-oncology. Watch Kevin Harrington explain why you can’t miss this event and register to participate online.
👉 ow.ly/BxBF50GXhe7
#immunooncology #immunotherapy #cancerresearch #immunonc
Rutella Lab retweeted
Sign up today ow.ly/wuaY50C0OXY and join us for Oncology October Part 3! Dr. Sergio Rutella, Nottingham Trent University, 'Immune correlates of TP53 mutational status in acute myeloid leukemia'. WED OCT 28 4PM GMT / 5PM CET #geneexpression #spatialgenomics #oncologyresearch
Rutella Lab retweeted
Make the most of your #ASH21 experience whether you're joining virtually or heading to Atlanta! 💻✈️ This year's featured hashtags can help you connect with your fellow attendees from wherever they join.
Don't miss out! Register today: loom.ly/0UWtAlU
Rutella Lab retweeted
Pre-Conference Programs begin today! The World Immunotherapy Council's 4th Young Investigator Symposium kicks off at 7:30 a.m. EST. Learn more: sitcancer.org/2021/program/p… #SITC21
Rutella Lab retweeted
It’s 5:30 AM & excited to be on @Delta headed to DCA for start of @WICouncil young investigators forum prior to #SITC21/@sitcancer Annual Mtg is my 1st in-person conference since Feb 2020/Looking forward to learning a good deal about anticancer immunity 2 #FinishCancer #sitc2021
Rutella Lab retweeted
Flotetuzumab as Salvage Immunotherapy for Refractory Acute Myeloid Leukemia pubmed.ncbi.nlm.nih.gov/3292…






















